HIGHLIGHTS
- who: Linzehao Li and colleagues from the Endocrine and Metabolic Diseases Hospital of Shandong First Medical, Shandong First Medical and Shandong Academy of Medical Sciences, Jinan, China have published the paper: Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
- what: The aim of this study was to further investigate the association between treatment of diabetes and AGEs. The authors investigated the inhibitory effect of allicin on the formation of AGEs through in_vivo and in_vitro experiments and whether allicin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.